2-Oxazolidinone → 3-[6-Methoxy-3-(5-methyl-1H-pyrazol-3-ylamino)-isoquinolin-1-ylmethyl]-oxazolidin-2-one
Reaction equation
CS([N:5]1[C:9]([CH3:10])=[CH:8][C:7]([NH:11][C:12]2[N:13]=[C:14]([CH2:24]OS(C)(=O)=O)[C:15]3[C:20]([CH:21]=2)=[CH:19][C:18]([O:22][CH3:23])=[CH:17][CH:16]=3)=[N:6]1)(=O)=O.[O:30]1[CH2:34][CH2:33][NH:32][C:31]1=[O:35]>>[CH3:23][O:22][C:18]1[CH:19]=[C:20]2[C:15](=[CH:16][CH:17]=1)[C:14]([CH2:24][N:32]1[CH2:33][CH2:34][O:30][C:31]1=[O:35])=[N:13][C:12]([NH:11][C:7]1[CH:8]=[C:9]([CH3:10])[NH:5][N:6]=1)=[CH:21]2Participants
3
Procedure
Similar procedure as described in the example 369d was used, starting from Methanesulfonic acid 3-(1-methanesulfonyl-5-methyl-1H-pyrazol-3-ylamino)-6-methoxy-isoquinolin-1-ylmethyl ester and Oxazolidin-2-one to give 5 mg of 3-[6-Methoxy-3-(5-methyl-1H-pyrazol-3-ylamino)-isoquinolin-1-ylmethyl]-oxazolidin-2-one as a yellow solid. LC-MS m/e 354 (MH+).
Sources & evidence
- ORD record
- ord-0c40d8c787a74e0eb48d483cacce902e
- Source dataset
- uspto-grants-2009_08
- Patent number
- US07572809B2
Reaction notes
Loading…